|

Standard of Care (SoC) Clinical Trials

6 actively recruiting trials across 6 locations

No change since May 2026

Pipeline

Phase 2: 1Phase 3: 3Phase 1/2: 1

Top Sponsors

  • EMD Serono Research & Development Institute, Inc.2
  • Novartis Pharmaceuticals1
  • New Horizon Medical Solutions1
  • Merck Sharp & Dohme LLC1
  • Cellvax Therapeutics Inc1

Indications

  • Cancer3
  • Lupus2
  • Systematic Lupus Erythematosus1
  • Cutaneous Lupus Erythematosus1
  • Cutaneous Lupus Erythematosus (CLE)1

Tucson, Arizona1 trial

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Arizona Cancer Center at UMC North ( Site 0018)

Phase 3

Fresno, California1 trial

A Prospective Clinical Study to Evaluate the Effectiveness and Safety of Xcell Amnio MatrixTM (XAM) in the Management of Chronic Non-healing DFUs

Limb Preservation Platform, Inc.

N/A

Los Angeles, California1 trial

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

Dermatology Research Associates - 300204025

Phase 3

Upland, California1 trial

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

Inland Rheumatology Clinical Trials, Inc.

Phase 3

Denver, Colorado1 trial

An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

Sarah Cannon Research Institute

Phase 1/2

Chicago, Illinois1 trial

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

University of Chicago Medicine, High-Risk and Advanced Prostate Cancer Clinic

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.